Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger M Nitsch

Showing results (21-30 of 175) with videos related to

Pageof 18
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2009
Abeta immunotherapy protects morphology and survival of adult-born neurons in doubly transgenic APP/PS1 miceBarbara Biscaro, Olle Lindvall, Christoph Hock, et al.
Neuro-Degenerative Diseases|February 7, 2018
Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical StudyMario Merlini, Tunahan Kirabali, Luka Kulic, et al.
Neuro-Degenerative Diseases|May 16, 2012
Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's diseaseBarbara Biscaro, Olle Lindvall, Giuseppina Tesco, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 20, 2007
Abeta oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanismsMarlen Knobloch, Mélissa Farinelli, Uwe Konietzko, et al.
Frontiers in Immunology|June 26, 2020
Oligomeric Forms of Human Amyloid-Beta(1-42) Inhibit Antigen PresentationChristoph Gericke, Anna Mallone, Britta Engelhardt, et al.
Current Alzheimer Research|November 20, 2012
Brief but chronic increase in allopregnanolone cause accelerated AD pathology differently in two mouse modelsSara K Bengtsson, Maja Johansson, Torbjorn Backstrom, et al.
Neurobiology of Disease|July 6, 2010
Vascular response to acetazolamide decreases as a function of age in the arcA beta mouse model of cerebral amyloidosisFelicitas L Princz-Kranz, Thomas Mueggler, Marlen Knobloch, et al.
Journal of Molecular Biology|March 16, 2011
The Osaka FAD mutation E22Δ leads to the formation of a previously unknown type of amyloid β fibrils and modulates Aβ neurotoxicityOxana Yu Ovchinnikova, Verena H Finder, Ivana Vodopivec, et al.
Annals of the New York Academy of Sciences|January 22, 2005
BACE1 overexpression regulates amyloid precursor protein cleavage and interaction with the ShcA adapterEmanuela Repetto, Claudio Russo, Valentina Venezia, et al.
Brain Pathology (Zurich, Switzerland)|September 1, 2020
Distinct changes in all major components of the neurovascular unit across different neuropathological stages of Alzheimer's diseaseTunahan Kirabali, Ruslan Rust, Serena Rigotti, et al.
Pageof 18

Showing results (21-30 of 175) with videos related to

Sort By:
Pageof 18
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2009
Abeta immunotherapy protects morphology and survival of adult-born neurons in doubly transgenic APP/PS1 miceBarbara Biscaro, Olle Lindvall, Christoph Hock, et al.
Neuro-Degenerative Diseases|February 7, 2018
Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical StudyMario Merlini, Tunahan Kirabali, Luka Kulic, et al.
Neuro-Degenerative Diseases|May 16, 2012
Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's diseaseBarbara Biscaro, Olle Lindvall, Giuseppina Tesco, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 20, 2007
Abeta oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanismsMarlen Knobloch, Mélissa Farinelli, Uwe Konietzko, et al.
Frontiers in Immunology|June 26, 2020
Oligomeric Forms of Human Amyloid-Beta(1-42) Inhibit Antigen PresentationChristoph Gericke, Anna Mallone, Britta Engelhardt, et al.
Current Alzheimer Research|November 20, 2012
Brief but chronic increase in allopregnanolone cause accelerated AD pathology differently in two mouse modelsSara K Bengtsson, Maja Johansson, Torbjorn Backstrom, et al.
Neurobiology of Disease|July 6, 2010
Vascular response to acetazolamide decreases as a function of age in the arcA beta mouse model of cerebral amyloidosisFelicitas L Princz-Kranz, Thomas Mueggler, Marlen Knobloch, et al.
Journal of Molecular Biology|March 16, 2011
The Osaka FAD mutation E22Δ leads to the formation of a previously unknown type of amyloid β fibrils and modulates Aβ neurotoxicityOxana Yu Ovchinnikova, Verena H Finder, Ivana Vodopivec, et al.
Annals of the New York Academy of Sciences|January 22, 2005
BACE1 overexpression regulates amyloid precursor protein cleavage and interaction with the ShcA adapterEmanuela Repetto, Claudio Russo, Valentina Venezia, et al.
Brain Pathology (Zurich, Switzerland)|September 1, 2020
Distinct changes in all major components of the neurovascular unit across different neuropathological stages of Alzheimer's diseaseTunahan Kirabali, Ruslan Rust, Serena Rigotti, et al.
Pageof 18